A PHASE II SINGLE-ARM TRIAL OF PALONOSETRON FOR THE PREVENTION OF ACUTE AND DELAYED CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS RECEIVING IRINOTECAN IN COMBINATION WITH BEVACIZUMAB

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Affronti, ML; Woodring, S; Herndon, JE; McSherry, F; Peters, KB; Friedman, HS; Desjardins, A; Freeman, W; Cheshire, S; Cone, C; Kalinowski, KH; Kim, J-Y; Lay, HH; Poillucci, V; Southerland, C; Tetterton, J; Vredenburgh, JJ

Published Date

  • October 1, 2012

Published In

Volume / Issue

  • 14 /

Start / End Page

  • 156 - 156

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

Conference Location

  • Washington, DC

Conference Start Date

  • November 15, 2012

Conference End Date

  • November 18, 2012